Serum c-erb B2 oncoprotein levels are elevated in recurrent and metastatic breast cancer

Clinical Biochemistry

Volumn 33, Issue 4, 2000, Pages 315-317

  Yasasever, Vildan ^a   Dincer, Maktav ^a   Camlica, Hakan ^a   Duranyildiz, Derya ^a   Dalay, Nejat ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b IU Oncology Institute   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RECURRENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE;

ADULT; AGED; ANALYSIS OF VARIANCE; BONE NEOPLASMS; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 0033848376     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(00)00068-0     Document Type: Article

References (10)

1. Amplification in tumors and benign tissue of breast cancer patients
2. Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer
3. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cells
4. Specificity of Hercep Test in determining HER-2/ neu status of breast cancers using the united states food and drug administration - Approved scoring system
5. Detection of HER-2/neu oncogene amplification in flow cytometry-sorted breast ductal cells by competitive polymerase chain reaction
6. Serum c-erb B2 levels in monitoring of operable breast cancer patients
7. Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer
8. Serum neu oncoprotein levels as a tumor marker in breast cancer
9. The prognostic significance of c-erbB-2 serum protein in metastatic breast cancer
10. Tissue expression and serum levels of HER-2/neu in patients with breast cancer